For the first time an infected woman defeated HIV, know what is the successful treatment
New Technology / For the first time an infected woman defeated HIV, know what is the successful treatment
New Technology - For the first time an infected woman defeated HIV, know what is the successful treatment
For the first time in America, doctors have succeeded in treating an HIV-infected woman and freeing her from the virus. According to doctors, the entire process of treatment has been completed through stem cell transplant.The stem cells were donated by a man who had a natural immunity against the HIV virus. A special ongoing study led by Dr. Ivonne Bryson of the University of California and Dr. Debra Persaud of the Johns Hopkins University in Baltimore focused on how many of the treatment procedures were carried out.During the treatment, doctors used umbilical cord blood for the first time to treat a woman's leukemia. At present, the woman has been healthy for 14 months, and has not needed any medicine.First time womanEarlier there have been two such cases when HIV patients got cured. One of them was of a white male, while the other was a male of South American descent. Both of them also had stem cell transplants, but those stem cells were taken from adults. Sharon Levin, president of the International AIDS Society, said, "Now the third report of treatment is coming and for the first time a woman has been treated and cured."This is how treatmentDoctors first conducted chemotherapy on HIV infected patients by testing them. in order to kill cancer cells. After that, stem cells from a person with a particular genetic mutation are transplanted into the patient's body. Researchers studying this believe that after transplant patients develop immunity to HIV.Gene therapy also effectiveAccording to K Levine, president of the AIDS Society, HIV is curable and gene therapy may be an effective treatment strategy in the future. According to the study, the key to the success of this treatment is the successful transplantation of HIV-resistant cells into the patient's body.